Disconnected systems – not a lack of technology – are slowing clinical trial execution and forcing site staff to bridge costly workflow gaps.
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- What Will Life Science Orgs Do When The AI Bill Comes Through?
- Clinical Trial Standards — What They Are And Why They're Indispensable
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
ON-DEMAND WEBINARS
Review the capabilities of this collection of ePRO applications, available on both web and mobile platforms, for enhancing hybrid or decentralized clinical trial experiences.
While advances in sensors and device design are improving wearability, successful data collection still hinges on participant adherence. The session highlights why addressing this can’t be an afterthought.
Explore how clinical trial sponsors can benefit from the growing use of electronic source (eSource) technology at research sites.
Explore how CTMS capabilities can help uncover hidden study risks with industry-standard questions in the CTMS library, score study risk based on likelihood, impact, and detectability, and manage key risk indicators.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![clinical-trial-tech-ai-GettyImages-2226144959]( "The Agentic AI Readiness Myths Costing Sponsors Time")
The Agentic AI Readiness Myths Costing Sponsors TimeMany clinical organizations believe they must clean data and unify systems before adopting agentic AI. New approaches show teams can start now, create value faster, and improve readiness as they scale.
-
![GettyImages-1026593952 tablet, data]( "Fomenting A Culture Of Analytical Excellence In Clinical Development")
Fomenting A Culture Of Analytical Excellence In Clinical DevelopmentBuilding an "analytics culture" in clinical research requires striking a balance between fast, flexible technologies and the right support for trial teams working to integrate these solutions.
-
![clinical-trials-tech-GettyImages-1867575053]( "Reserving Data Integrity With Retrospective Manual Entry")
Reserving Data Integrity With Retrospective Manual EntryA look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
![car on winding road-GettyImages-2157089736]( "Frequently Asked Questions About Travel For Clinical Trial Patients")
Frequently Asked Questions About Travel For Clinical Trial PatientsFind answers to the most common questions about trial travel support, from booking rides to arranging complex logistics for caregivers and patients.
-
![GettyImages-966826582 data, research, analytics]( "8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development")
8 Key Applications Of Real-World Data In Multiple Myeloma Therapy DevelopmentExplore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.
-
![clinical-trials-patients-GettyImages-1629549075]( "When Early CRO Wins Quietly Create Long-Term Study Risk")
When Early CRO Wins Quietly Create Long-Term Study RiskDiscover how overemphasizing early trial milestones can compromise long-term execution. Learn key strategies to build sustainable operational frameworks for lasting study success.
-
Optimizing Integrated Registries
Integrated registries are vital to understanding disease progression, but effective integration requires a combination of data science, technical expertise, and IT architecture supporting real-world evidence generation.
-
![GettyImages-1408596915 eTMF]( "Achieving Faster, Simpler Validation Through Crowdsource UAT")
Achieving Faster, Simpler Validation Through Crowdsource UATAn approach most often seen in the larger tech space, crowdsource UAT can offer several potential advantages for the clinical trial industry and eTMF validation.
-
![GettyImages-2155531148 electronic data, ePRO, eCOA]( "Why ePROs In Oncology Are Perfect For Capturing The Patient's Voice")
Why ePROs In Oncology Are Perfect For Capturing The Patient's VoiceRecently released FDA guidance showcases why electronic patient-reported outcomes (ePROs) are ideal for capturing the “voice” of the patient. See how ePRO eases oncology trials.
-
![etmf-sites-GettyImages-1030071552]( "Five Questions Every Sponsor Must Ask Before Selecting An eTMF Platform")
Five Questions Every Sponsor Must Ask Before Selecting An eTMF PlatformLean teams need a strategic eTMF choice. The right platform speeds startup, cuts manual oversight, strengthens site collaboration, and keeps studies inspection‑ready as portfolios grow.
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- The Data Was Already There: RWE's Real Bottleneck Is People
RECENT NEWSLETTERS
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
